Agilent Technologies, Inc. (A) Stock
A Key Statistics
About Agilent Technologies, Inc.
Agilent Technologies, Inc. delivers specialized, application-focused technologies and services to the global life sciences, diagnostics, and applied chemistry industries. Its Life Sciences and Applied Markets segment provides a comprehensive portfolio of analytical instrumentation. This includes liquid chromatography (LC) and gas chromatography (GC) systems, often integrated with mass spectrometry (MS) for advanced analysis (LC-MS, GC-MS). They also offer inductively coupled plasma mass spectrometry (ICP-MS), atomic absorption (AA), microwave plasma-atomic emission spectrometry (MP-AES), and inductively coupled plasma optical emission spectrometry (ICP-OES) instruments, alongside Raman spectroscopy for material characterization. Beyond spectroscopy, the segment supplies cell analysis solutions such as plate-based assays, flow cytometers, real-time cell analyzers, imaging systems, and microplate readers. Complementing these are various laboratory software, information management platforms, data analytics tools, automated and robotic lab systems, dissolution testing equipment, vacuum technology, and general measurement solutions. The Diagnostics and Genomics division offers cutting-edge tools for genetic and diagnostic research. These encompass arrays designed for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression analysis. This segment also provides target enrichment solutions for next-generation sequencing, along with software for genetic data management and interpretation. Furthermore, it synthesizes custom oligonucleotides. Other significant offerings include immunohistochemistry (IHC), in situ hybridization (ISH), hematoxylin and eosin (H&E) staining, and specialized staining solutions. The division also supplies consumables and software essential for quality control analysis of nucleic acid samples, as well as reagents for turbidimetry and flow cytometry applications. A key area of development for this segment is liquid-based pharmacodiagnostics. Agilent CrossLab, the third segment, focuses on providing essential laboratory consumables and services. Its product range features GC and LC columns, products for sample preparation, custom chemical formulations, and various supplies for laboratory instruments. Complementary services include expert support for startup, ongoing operations, training, compliance, Software-as-a-Service (SaaS) offerings, asset management, and professional consultation. The company's products reach customers through a diverse sales network, including direct sales teams, distributors, resellers, manufacturer's representatives, and its e-commerce platforms. Agilent Technologies, Inc. was established in 1999 and maintains its corporate headquarters in Santa Clara, California.
CEO: Padraig McDonnell. Company website
A — Frequently Asked Questions
What is the A stock price today?
Agilent Technologies, Inc. (A) trades at $176.95, down 0.52% on the day, as of Nov 12, 2026 09:20 UTC.
What is Agilent Technologies, Inc.'s market cap?
Agilent Technologies, Inc. has a market capitalisation of $49.89B, calculated from the live A share price and shares outstanding.
What is the P/E ratio of A?
A trades at a trailing P/E of 34.81, from earnings per share of $5.08 over the last twelve months.
How much revenue does Agilent Technologies, Inc. make?
Agilent Technologies, Inc. generated revenue of $7.37B over the trailing twelve months, which puts the stock at 6.77 times sales.
Does A pay a dividend?
Yes. Agilent Technologies, Inc. pays a dividend yielding 0.69% on the current share price.
What is the 52-week range for A?
A has traded between $108.35 and $182.99 over the past 52 weeks, and the last price is 3.3% below that high.
Is Agilent Technologies, Inc. profitable?
Yes. Agilent Technologies, Inc. keeps 19.53% of revenue as net income over the trailing twelve months.
What is the analyst price target for A?
Wall Street analysts rate A Buy, with an average price target of $174.29, 1.5% below the current price.
What sector is Agilent Technologies, Inc. in?
Agilent Technologies, Inc. is classified under the Healthcare sector and the Medical - Diagnostics & Research industry, and is domiciled in US.
Who is the CEO of Agilent Technologies, Inc.?
Padraig McDonnell is the chief executive of Agilent Technologies, Inc., which employs 18,200 people.
Where can I track A in real time?
QFI Terminal shows A with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
See A live in QFI Terminal
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open A in Terminal See plans